Search Results

BioCapital

LumaCyte Launches New Compact Radiance® Instrument for Advanced Therapy Biomanufacturing & QC Environments

LumaCyte is proud to announce the launch of their newly redesigned flagship Radiance® instrument to meet growing demand for Laser Force Cytology™ precision analytics in space-constrained biomanufacturing facilities.

October 24, 2023

·

5 min read

BioCapital

LumaCyte Accelerates Global Growth, Closing Strategic Series B Financing

LumaCyte announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand.

September 6, 2023

·

5 min read

Business

LumaCyte Fueled for Growth, Names Top Life Sciences Industry Executives to Board

LumaCyte Corporation announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®.

March 8, 2022

·

3 min read

Business

LumaCyte Appoints Vaccine Manufacturing Expert to Scientific Advisory Board

LumaCyte , a leader in advanced label-free single-cell analytics through its novel Laser Force Cytology™ (LFC™) platform, announces today the addition of Jim Robinson to its Scientific Advisory Board (SAB).

April 20, 2021

·

4 min read

BioCapital

LumaCyte’s Laser Force Cytology Accelerating Gene Therapy Production

LumaCyte, an advanced bioanalytical instrumentation company has demonstrated a significant advancement using its transformative Laser Force Cytology instrument, Radiance®.

June 2, 2020

·

4 min read

Business

LumaCyte Expands into Europe Tackling Expansive Vaccine and Cell and Gene Therapy Markets

LumaCyte, an advanced bioanalytical instrumentation company specializing in vaccine and cell and gene therapy bioprocess, production, and R&D analytical capabilities, announces its expansion into Europe with the establishment of LumaCyte, B.V. in The Netherlands.

February 20, 2020

·

2 min read

Policy

LumaCyte Primed for Significant Global Growth: CE Mark Opens European Market

LumaCyte, an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA, announces the third doubling of their manufacturing and laboratory space.

September 12, 2019

·

2 min read

Business

LumaCyte Joins The National Institute For Innovation In Manufacturing Biopharmaceuticals (NIIMBL)

September 8, 2017

·

3 min read

BioCapital

LumaCyte Invited For Keynote Presentation At NIWeek 2016

August 3, 2016

·

1 min read

BioCapital

To Advance Research, LumaCyte Scientists Look At Cells In A New Light

August 12, 2015

·

3 min read